INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Iria Bastón-Rey 1
Manuel Barreiro de Acosta
Marta Costa
Cristina Calviño Suarez
Maria Violeta Mauriz Barreiro
Daniel de la Iglesia-Garcia
Jaime González
Rocío Ferreiro-Iglesias
Juan Enrique Dominguez-Munoz
1 University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]